D. Michael Olive


Dr. Olive received his Ph.D. in medical microbiology from Loyola University Stritch School of Medicine in Chicago. After postdoctoral research at the University of Illinois Medical Center investigating transcriptional control in SV40, he took a position with Pharmacia as a molecular biologist where he began developing the use of DNA probes for microbial diagnostics. In 1984, he was recruited by the World Health Organization as a scientist in the WHO/CDC program to eradicate poliovirus. In 1990 he returned to the United States as the Senior Manager of Assay Integration for GENE-TRAK/Vysis, applying a new nucleic acid amplification technology to the detection of microbial pathogens. He left after five years to help found Third Wave Technologies where his research team invented and developed a new nucleic acid amplification technology, the Invader. He has subsequently held positions as Vice President of Business Development for Applied Spectral Imaging and Vice President of Translational Research for LI-COR Biosciences. At LI-COR, he led the development of near-infrared dyes and contrast agents for image-guided cancer surgery. Currently, he is a consultant in a variety of areas and serves as an Adjunct Professor of Biology at Nebraska Wesleyan University where he is pursuing his interests of developing lytic bacteriophage as potential therapeutic agents for Methicillin-resistant Staphylococcus aureus and other bacterial pathogens as well as a purse-friendly, easily-to-use date rape drug detection kit.

Research Interests:

Methicillin resistant Staphylococci, passive antibiotic resistance, bacteriophage antimicrobials, and detection of date rape drugs.

Open Access Journals

Recently Released Issues

Social Network

Loading ....
Loading ....
Loading ....

Abstracting and Indexing

Boffin Access use Crossref Similarity Check for averting plagiarism


Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to

Send Information

Subscribe to our Newsletter

Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.


We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.

Do you have an idea or suggestion that can influence the Open Access community? Send an email to: support@boffinaccess.org